Eagle Asset Management Inc. lessened its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 216,168 shares of the biotechnology company’s stock after selling 2,054 shares during the quarter. Eagle Asset Management […]
Sarepta Therapeutics (NASDAQ:SRPT) Upgraded at Oppenheimer kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Brokers Issue Forecasts for Sarepta Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:SRPT) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report)’s share price gapped up before the market opened on Thursday following a stronger than expected earnings report. The stock had previously closed at $130.90, but opened at $140.00. Sarepta Therapeutics shares last traded at $136.00, with a volume of 574,101 shares changing hands. The biotechnology company reported […]
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fourteen brokerages that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average […]